Dermatomyositis recalcitrant to treatment associated with occult malignancy.
作者信息
Kane Jennifer, Bowerman Kimberly, Qureshi Abrar A, Moustafa Farah
机构信息
Department of Dermatology, Rhode Island Hospital, Providence, Rhode Island.
Warren Alpert Medical School at Brown University, Providence, Rhode Island.
出版信息
JAAD Case Rep. 2019 Nov 22;5(12):1084-1087. doi: 10.1016/j.jdcr.2019.09.026. eCollection 2019 Dec.
Abstract
摘要
相似文献
1
Dermatomyositis recalcitrant to treatment associated with occult malignancy.
JAAD Case Rep. 2019 Nov 22;5(12):1084-1087. doi: 10.1016/j.jdcr.2019.09.026. eCollection 2019 Dec.
2
Unsuspected Active Ulcerative Colitis in a Patient With Dermatomyositis: A Rare Association Detected on F-FDG PET/CT During the Search for an Occult Malignancy.
Indian J Nucl Med. 2017 Apr-Jun;32(2):130-132. doi: 10.4103/0972-3919.202238.
3
The relationship of dermatomyositis and polymyositis to internal malignancy.
Arch Dermatol. 1980 Mar;116(3):295-8.
4
Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis.
Semin Arthritis Rheum. 2019 Aug;49(1):140-144. doi: 10.1016/j.semarthrit.2018.10.021. Epub 2018 Nov 2.
5
Dysphagia as a presenting symptom in a case of dermatomyositis and occult gastric malignancy.
Nepal Med Coll J. 2005 Jun;7(1):77-8.
6
A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report.
J Med Case Rep. 2016 Feb 6;10:34. doi: 10.1186/s13256-016-0816-8.
7
Dermatomyositis.
Dermatol Online J. 2004 Nov 30;10(3):7.
8
A case of dermatomyositis with esophageal fistula in whom blind mucosal biopsy detected occult oropharyngeal carcinoma.
Case Rep Dermatol. 2014 Nov 20;6(3):268-73. doi: 10.1159/000368274. eCollection 2014 Sep-Dec.
9
Paraneoplastic Dermatomyositis with Cutaneous and Myopathic Disease Responsive to Adrenocorticotropic Hormone Therapy.
J Clin Aesthet Dermatol. 2017 Jan;10(1):57-62. Epub 2017 Jan 1.
10
Case Report: amyopathic dermatomyositis associated with transformed malignant lymphoma.
Am J Med Sci. 1996 May;311(5):240-2. doi: 10.1097/00000441-199605000-00008.
本文引用的文献
1
Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis.
J Am Acad Dermatol. 2019 May;80(5):1364-1370. doi: 10.1016/j.jaad.2018.11.023. Epub 2018 Nov 17.
2
Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.
JAMA Dermatol. 2018 Jan 1;154(1):44-51. doi: 10.1001/jamadermatol.2017.3758.
3
Angioimmunoblastic T-cell lymphoma mimicking dermatomyositis.
J Dermatol. 2016 Jul;43(7):837-9. doi: 10.1111/1346-8138.13299. Epub 2016 Feb 22.
4
Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.
PLoS One. 2014 Apr 8;9(4):e94128. doi: 10.1371/journal.pone.0094128. eCollection 2014.
5
Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.
Arthritis Rheum. 2013 Nov;65(11):2954-62. doi: 10.1002/art.38093.
6
Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Medicine (Baltimore). 2009 Mar;88(2):91-97. doi: 10.1097/MD.0b013e31819da352.
7
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
Br J Cancer. 2001 Jul 6;85(1):41-5. doi: 10.1054/bjoc.2001.1699.
8
Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Br J Dermatol. 2001 Apr;144(4):825-31. doi: 10.1046/j.1365-2133.2001.04140.x.
9
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.
Lancet. 2001 Jan 13;357(9250):96-100. doi: 10.1016/S0140-6736(00)03540-6.
10
Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.
Ann Oncol. 1995 Sep;6(7):659-64. doi: 10.1093/oxfordjournals.annonc.a059281.
Zotero 插件